More
    Guided Solutions - Connecting Talent With Innovation/div>

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing in partnership with existing investor Catalio Capital Management. Additionally, new...

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...

    Perfuze wins FDA clearance for standalone aspiration catheter

    Perfuze announced that it received FDA 510(k) clearance for its Millipede88 aspiration catheter. Galway, Ireland-based Perfuze designed the catheter for rapid and complete clot removal...

    Endo Tools Therapeutics receives FDA 510(k) clearance for EZFuse

    Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for...

    Prodeon gets FDA clearance for BPH-treating nitinol implant

    Prodeon Medical announced that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Innovation

    Regulatory Approvals

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...

    Perfuze wins FDA clearance for standalone aspiration catheter

    Perfuze announced that it received FDA 510(k) clearance for its Millipede88 aspiration catheter. Galway, Ireland-based Perfuze designed the catheter for rapid and complete clot removal...

    Endo Tools Therapeutics receives FDA 510(k) clearance for EZFuse

    Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for...

    Prodeon gets FDA clearance for BPH-treating nitinol implant

    Prodeon Medical announced that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology...

    M&A

    Archives

    Latest articles